BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24176729)

  • 1. Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International Scleroderma Renal Crisis Survey.
    Hudson M; Baron M; Tatibouet S; Furst DE; Khanna D;
    Semin Arthritis Rheum; 2014 Apr; 43(5):666-72. PubMed ID: 24176729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment.
    Walker JG; Ahern MJ; Smith MD; Coleman M; Pile K; Rischmueller M; Cleland L; Roberts-Thomson PJ
    Intern Med J; 2003; 33(5-6):216-20. PubMed ID: 12752889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients.
    Teixeira L; Mouthon L; Mahr A; Berezné A; Agard C; Mehrenberger M; Noël LH; Trolliet P; Frances C; Cabane J; Guillevin L;
    Ann Rheum Dis; 2008 Jan; 67(1):110-6. PubMed ID: 17557890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors.
    Steen VD; Costantino JP; Shapiro AP; Medsger TA
    Ann Intern Med; 1990 Sep; 113(5):352-7. PubMed ID: 2382917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of scleroderma renal crisis: a long-term observational study.
    Cozzi F; Marson P; Cardarelli S; Favaro M; Tison T; Tonello M; Pigatto E; De Silvestro G; Punzi L; Doria A
    Nephrol Dial Transplant; 2012 Dec; 27(12):4398-403. PubMed ID: 22859795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleroderma renal crisis.
    Bose N; Chiesa-Vottero A; Chatterjee S
    Semin Arthritis Rheum; 2015 Jun; 44(6):687-94. PubMed ID: 25613774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.
    Steen VD; Medsger TA
    Arthritis Rheum; 1998 Sep; 41(9):1613-9. PubMed ID: 9751093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of scleroderma renal crisis.
    Steen VD; Medsger TA
    Ann Intern Med; 2000 Oct; 133(8):600-3. PubMed ID: 11033587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis.
    Bütikofer L; Varisco PA; Distler O; Kowal-Bielecka O; Allanore Y; Riemekasten G; Villiger PM; Adler S;
    Arthritis Res Ther; 2020 Mar; 22(1):59. PubMed ID: 32209135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scleroderma renal crisis: patient characteristics and long-term outcomes.
    Penn H; Howie AJ; Kingdon EJ; Bunn CC; Stratton RJ; Black CM; Burns A; Denton CP
    QJM; 2007 Aug; 100(8):485-94. PubMed ID: 17601770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An International, Web-Based, Prospective Cohort Study to Determine Whether the Use of ACE Inhibitors prior to the Onset of Scleroderma Renal Crisis Is Associated with Worse Outcomes-Methodology and Preliminary Results.
    Hudson M; Baron M; Lo E; Weinfeld J; Furst DE; Khanna D
    Int J Rheumatol; 2010; 2010():. PubMed ID: 20936135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleroderma renal crisis.
    Mouthon L; Bussone G; Berezné A; Noël LH; Guillevin L
    J Rheumatol; 2014 Jun; 41(6):1040-8. PubMed ID: 24833760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls.
    Guillevin L; Bérezné A; Seror R; Teixeira L; Pourrat J; Mahr A; Hachulla E; Agard C; Cabane J; Vanhille P; Harle JR; Deleveaux I; Mouthon L
    Rheumatology (Oxford); 2012 Mar; 51(3):460-7. PubMed ID: 22087012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Scleroderma renal crisis (SRC): hypertensive, normotensive].
    Endo H
    Nihon Rinsho Meneki Gakkai Kaishi; 2000 Dec; 23(6):656-60. PubMed ID: 11210764
    [No Abstract]   [Full Text] [Related]  

  • 16. [A retrospective clinical analysis of 16 patients with scleroderma renal crisis].
    Zhou J; Xu D; Hou Y; Wang Q; Li M; Zeng X
    Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):125-9. PubMed ID: 25907843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of scleroderma renal crisis.
    Nagaraja V
    Curr Opin Rheumatol; 2019 May; 31(3):223-230. PubMed ID: 30870219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and long-term outcomes of Chinese patients with scleroderma renal crisis.
    Zhou J; Hou Y; Wang Q; Li M; Zeng X; Xu D
    Int J Rheum Dis; 2020 Aug; 23(9):1194-1200. PubMed ID: 32700455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE inhibitors for scleroderma renal crisis.
    Ann Intern Med; 1991 Feb; 114(3):249-50. PubMed ID: 1984753
    [No Abstract]   [Full Text] [Related]  

  • 20. [Renal crisis in scleroderma].
    Fagel WJ; van Es LA
    Ned Tijdschr Geneeskd; 1992 Dec; 136(52):2588-90. PubMed ID: 1480244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.